Chronic Obstructive Pulmonary Disease (COPD) Market Forecast Report and Company Analysis 2024-2032 Featuring AstraZeneca, Pfizer, GSK, Novartis, Astellas, Abbott, Boehringer Ingelheim, Almirall
10. September 2024 05:12 ET
|
Research and Markets
Dublin, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease, Market Report, Forecast by Types, Treatment Types, Distribution Channels, Countries and Company Analysis,...
Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market Report 2024: Comprehensive Insights About 65+ Companies and 70+ Pipeline Drugs
17. Juli 2024 09:07 ET
|
Research and Markets
Dublin, July 17, 2024 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report...
Chronic Obstructive Pulmonary Disease - Pipeline Insight, 2023: Over 65 Companies Developing Drugs for COPD with Several in Phase III of Testing
05. April 2023 04:33 ET
|
Research and Markets
Dublin, April 05, 2023 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease - Pipeline Insight, 2023" clinical trials has been added to ResearchAndMarkets.com's offering.This report...
Global Chronic Obstructive Pulmonary Disease Market Size To Grow USD 35.9 Billion By 2030 | CAGR of 8.2%
22. März 2023 12:30 ET
|
SPHERICAL INSIGHTS LLP
New York, United States, March 22, 2023 (GLOBE NEWSWIRE) -- The Global Chronic Obstructive Pulmonary Disease Market Size to grow from USD 18.20 billion in 2021 to USD 35.90 billion by 2030, at a...
Anti-Asthmatics And COPD Drugs Global Market Report 2023: A $117.36 Billion Market by 2027 Featuring Novartis, Merck, GSK, Boehringer Ingelheim, AstraZeneca, Roche, Teva, Vectura, Pfizer and Abbott
23. Februar 2023 07:58 ET
|
Research and Markets
Dublin, Feb. 23, 2023 (GLOBE NEWSWIRE) -- The "Anti-Asthmatics And COPD Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.Major players in the...
Global Chronic Obstructive Pulmonary Disease (COPD) Market Report 2023 - 2028: Featuring AstraZeneca, Pfizer, GlazoSmithKline and Novartis Among Others
23. Januar 2023 10:03 ET
|
Research and Markets
Dublin, Jan. 23, 2023 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease (COPD) Market, Global Forecast 2023-2028, Industry Trends, Growth, Insight, Impact of Inflation, Company...
Global Chronic Obstructive Pulmonary Disease Markets, Epidemiology and Patient Flow Report 2020-2035: Focus on US, Germany, France, Italy, Spain, UK, Japan, G7 Countries
14. Mai 2021 08:08 ET
|
Research and Markets
Dublin, May 14, 2021 (GLOBE NEWSWIRE) -- The "Global Chronic Obstructive Pulmonary Disease Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering. Global...